Plasma exchange for drug-induced liver injury with chronic liver disease
Treatments studied
Part of Digestive system clinical trials.
This trial tests whether a treatment called plasmapheresis (plasma exchange) can help people with severe liver damage caused by medications when they also have chronic liver disease. The treatment filters the blood to remove harmful substances, which may improve liver function and recovery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 75 years old.
- You must have chronic liver disease (known or not known before).
- Your liver damage must be caused by a drug or medication.
- Your liver damage must be severe, shown by high bilirubin or blood clotting problems.
- You cannot have active infections, cancer, or other serious conditions listed in the full criteria.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether steroids (glucocorticoids) can help people with acute liver injury caused by a drug, especially when bilirubin levels are high. It aims to see if steroids can reduce liver damage and improve recovery.
This trial builds a prediction model to identify drug-related liver injury (DILI) by looking at your blood test patterns, timing, and expert diagnosis. It may help improve how doctors recognize this condition earlier and more accurately.
This trial tests whether a treatment called plasma exchange (which removes harmful substances from your blood and replaces them with healthy plasma) can help improve the function of other organs, like the kidneys or lungs, in people with advanced liver failure. It aims to find out if this treatment helps you recover better and to identify markers that show if the treatment is working.
This study compares a blood-filtering treatment called therapeutic plasma exchange with standard medicines for people with severe autoimmune hepatitis. It aims to see if plasma exchange can improve outcomes when a liver transplant is not available soon.
This trial tests whether a higher volume of plasma exchange (cleaning the blood to remove toxins) works better than the standard amount for children with acute liver failure who are not improving with usual care.
This study compares giving a higher versus a standard amount of plasma exchange, a treatment that cleans your blood, to see if it helps people with sudden liver failure and brain swelling. It aims to find out if a higher dose can better reduce brain pressure and improve outcomes.
Hear when a new Drug Induced Liver Injury trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.